Daniel Baker - Jan 28, 2025 Form 4 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
Director
Signature
/s/ Neha Krishnamohan, Attorney-in-Fact
Stock symbol
ARTV
Transactions as of
Jan 28, 2025
Transactions value $
$0
Form type
4
Date filed
1/29/2025, 04:33 PM
Previous filing
Nov 29, 2024
Next filing
Mar 25, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARTV Director Stock Option (Right to Buy) Award $0 +27.5K $0.00 27.5K Jan 28, 2025 Common Stock 27.5K $5.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares vested following the grant date, with the remaining shares vesting monthly over an additional two years following January 28, 2025,